# Sensible

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sensible

- Industry: Biotechnology
- Headquarters: UK
- Total disclosed funding: $27M
- Latest round: Series A (Oct 6, 2026)
- Investors on record: 9

## About

Founded in 2021, Sensible is a biotechnology company that develops cell-based mRNA design, optimization, and manufacturing platform for therapeutic applications.

## Funding rounds

- Series A, Oct 6, 2026, $27M — In-Q-Tel, Y Combinator, Isomer Capital, BlueYard Capital, Backed VC, Civilization Ventures, OTB Ventures, KAYA, Recode

## Investors

- In-Q-Tel (https://capitalatlas.ai/funds/in-q-tel) — Series A
- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Series A
- Isomer Capital (https://capitalatlas.ai/funds/isomer-capital) — Series A
- BlueYard Capital (https://capitalatlas.ai/funds/blueyard-capital) — Series A
- Backed VC (https://capitalatlas.ai/funds/backed-vc) — Series A
- Civilization Ventures (https://capitalatlas.ai/funds/civilization-ventures) — Series A
- OTB Ventures (https://capitalatlas.ai/funds/otb-ventures) — Series A
- KAYA (https://capitalatlas.ai/funds/kaya) — Series A
- Recode (https://capitalatlas.ai/funds/recode) — Series A